NCT06823362View on ClinicalTrials.gov

Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

April 10, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2025

Conditions

HealthyHealthy Donors

Interventions

DRUG

Pentoxifylline

400 mg

DRUG

Pentoxifylline

400 mg

All Listed Sponsors

lead

Centro de Atencion e Investigacion Medica

NETWORK